208 related articles for article (PubMed ID: 32577996)
1. Expression levels of SCCA and CYFRA 21-1 in serum of patients with laryngeal squamous cell carcinoma and their correlation with tumorigenesis and progression.
Ji M; Zhang LJ
Clin Transl Oncol; 2021 Feb; 23(2):289-295. PubMed ID: 32577996
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
[TBL] [Abstract][Full Text] [Related]
3. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
Feng XY; Li JH; Li JZ; Han ZX; Xing RD
Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
[TBL] [Abstract][Full Text] [Related]
4. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
5. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
6. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
7. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvik J; Kucera R; Topolcan O; Celakovsky P; Pesta M; Kholova I; Plzak J; Ludvikova M
Anticancer Res; 2019 Sep; 39(9):5171-5177. PubMed ID: 31519630
[TBL] [Abstract][Full Text] [Related]
10. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Serum SCCA and CYFRA 2 1-1, Tissue Ki-67, and Clinicopathological Factors in Patients with Esophageal Squamous Cell Carcinoma.
Sunpaweravong S; Puttawibul P; Sunpaweravong P; Nitiruangjaras A; Boonyaphiphat P; Kemapanmanus M
J Med Assoc Thai; 2016 Mar; 99(3):331-7. PubMed ID: 27276745
[TBL] [Abstract][Full Text] [Related]
12. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA
Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum squamous cell carcinoma antigen and cytokeratin fragment antigen 21-1 for sinonasal inverted papilloma: an exploratory study.
Zhang Z; Xu B; Wang L; Yan X; Li S; Jiang Y; Yu L
Rhinology; 2024 Jun; 62(3):353-361. PubMed ID: 38189590
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.
Zhang HQ; Wang RB; Yan HJ; Zhao W; Zhu KL; Jiang SM; Hu XG; Yu JM
Asian Pac J Cancer Prev; 2012; 13(1):199-203. PubMed ID: 22502668
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.
Han Y; Ren Z; Liu Y; Liu Y
Ear Nose Throat J; 2024 May; 103(5):NP278-NP288. PubMed ID: 34672822
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
[TBL] [Abstract][Full Text] [Related]
17. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of serum SCCA and CYFRA21-1 levels on radiotherapy efficacy and prognosis in patients with non-small cell lung cancer.
Chen F; Zhang X
Biotechnol Genet Eng Rev; 2023 May; ():1-10. PubMed ID: 37153975
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of combined examination of pretreatment serum CYFRA21-1 and SCCAg in cervical cancer patients.
Xiong Y; Peng XP; Liang LZ; Zheng M; Li JD
Ai Zheng; 2009 Jan; 28(1):64-7. PubMed ID: 19448420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
